Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
Pfizer supports Investigator Sponsored Research (ISR) projects that advance medical and scientific knowledge about our therapies.
Característiques principals
An ISR is a type of grant that supports an independent research study where the investigator or organization is the sponsor of the study and where Pfizer provides financial and/or non-financial support for the development or refinement of specific and defined medical knowledge relating to a Pfizer asset. Pfizer also supports general research projects focused on the development or refinement of specific and defined medical knowledge unrelated to a Pfizer asset. This grant type is used to support research that does not include the study of a Pfizer asset, including health services research unrelated to a Pfizer asset, registry development and/or queries unrelated to a Pfizer asset, and outcomes research unrelated to a Pfizer asset.
Lloc de presentació
IMIM and PSMAR staff who need more information should contact::
Competitive Funding. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
Carol Barnwell: cbarnwell@imim.net Ext.: 1670
Marta López: mlopez4@imim.net Ext.: 1576
Convocatòria (URL)
https://www.pfizer.com/about/programs-policies/grants/investigator-sponsored-research
Submission Portal:
https://www.cybergrants.com/pls/cybergrants/ao_login.login?x_gm_id=4617&x_proposal_type_id=50610
Requisits
  • All fields must be completed in English and any uploaded documents must be in English
  • If approved, the requesting organization will be the contracting organization to which the grant will be paid
  • Pfizer cannot provide grants to individuals, individually owned private physician practices or informal groups which are not legal entities
  • To submit your request to Pfizer you must answer all questions in the online application system available at the Application Portal.
  • Durada
    There are no submission deadlines. Applicants must expect to wait 90 days for a response from Pfizer.

    Arxius

    Arxiu
    GMG_ResearchApplication_ExternalPreview.pdf